Your browser doesn't support javascript.
loading
No association of a risk variant for severe COVID-19 with HIV protection in three cohorts of highly exposed individuals.
Sironi, Manuela; Cagliani, Rachele; Biasin, Mara; Lo Caputo, Sergio; Saulle, Irma; Forni, Diego; Real, Luis Miguel; Pineda, Juan Antonio; Exposito, Almudena; Saez, María Eugenia; Sinangil, Faruk; Forthal, Donald; Caruz, Antonio; Clerici, Mario.
Afiliação
  • Sironi M; Scientific Institute IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, 23842 Lecco, Italy.
  • Cagliani R; Scientific Institute IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, 23842 Lecco, Italy.
  • Biasin M; Laboratory of Immunobiology, Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
  • Lo Caputo S; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Saulle I; Laboratory of Immunobiology, Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
  • Forni D; Scientific Institute IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, 23842 Lecco, Italy.
  • Real LM; Unidad de Enfermedades Infecciosas y Microbiología Clínica. Hospital Universitario de Valme, 41014 Sevilla, Spain.
  • Pineda JA; Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología. Facultad de Medicina. Universidad de Málaga, 29010 Málaga, Spain.
  • Exposito A; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
  • Saez ME; Unidad de Enfermedades Infecciosas y Microbiología Clínica. Hospital Universitario de Valme, 41014 Sevilla, Spain.
  • Sinangil F; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
  • Forthal D; Departamento de Medicina. Facultad de Medicina. Universidad de Sevilla. Instituto de Biomedicina de Sevilla (IBiS), 41013 Sevilla, Spain.
  • Caruz A; Unidad de Inmunogenética, Genética, Departamento de Biología Experimental, Universidad de Jaén, 23071 Jaén, Spain.
  • Clerici M; Centro Andaluz de Estudios Bioinformáticos, 41092 Sevilla, Spain.
PNAS Nexus ; 1(3): pgac138, 2022 Jul.
Article em En | MEDLINE | ID: mdl-36741450
ABSTRACT
An extended haplotype on chromosome 3 is the major genetic risk factor for severe COVID-19. The risk haplotype, which was inherited from Neanderthals, decreases the expression of several cytokine receptors, including CCR5. Recently, a study based on three general population cohorts indicated that the minor allele of one of the variants in the haplotype (rs17713054) protects against HIV infection. We thus expected this allele to be over-represented in highly exposed individuals who remain uninfected (exposed seronegative individuals, ESN). To perform a meta-analysis, we genotyped rs17713054 in three ESN cohorts of European ancestry exposed to HIV through different routes. No evidence of association was detected in the single cohorts. The meta-analysis also failed to detect any effect of the variant on protection from HIV-1. The same results were obtained in a Cox-regression analysis for the time to seroconversion. An in-vitro infection assay did not detect differences in viral replication as a function of rs17713054 genotype status. We conclude that the rs17713054 minor allele is not associated with the ESN phenotype and does not modulate HIV infection in vitro.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: PNAS Nexus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: PNAS Nexus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália